Gilead's Drug Prevents Lung Damage In COVID-19 Study On Monkeys: Report

Gilead Sciences Inc's antiviral drug, remdesivir, prevented lung disease in macaque monkeys infected with the new coronavirus, a study published in medical journal Nature showed on Tuesday.